Eubiotics Market Size $9.63 Billion by 2030
Report Overview:
The Global Eubiotics Market achieved a valuation of $4.87 Billion in 2022 and is anticipated to exceed $9.63 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 8.9% during the forecast period from 2024 to 2032.
Key Market Players:
DSM (Netherlands), Novus International Inc. (U.S.), UAS Laboratories (U.S.) Lallemand Inc. (Canada), Calpis Co. Ltd. (Japan), Advanced BioNutrition Corp. (U.S.), BENEO (Germany), BEHN MEYER (Germany), Lesaffre Group (France)